Entrectinib in Two Pediatric Patients With Inflammatory Myofibroblastic Tumors Harboring ROS1 or ALK Gene Fusions

被引:15
|
作者
Ambati, Srikanth R. [1 ]
Slotkin, Emily K. [1 ]
Chow-Maneval, Edna [2 ]
Basu, Ellen M. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA
[2] Ignyta, San Diego, CA USA
基金
美国国家卫生研究院;
关键词
LYMPHOMA KINASE ALK; CLINICAL-RESPONSE; PAN-TRK; INHIBITOR; SARCOMA;
D O I
10.1200/PO.18.00095
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:1 / 6
页数:6
相关论文
共 50 条
  • [31] Combined effect of cabozantinib and gefitinib in crizotinib-resistant lung tumors harboring ROS1 fusions
    Kato, Yuka
    Ninomiya, Kiichiro
    Ohashi, Kadoaki
    Tomida, Shuta
    Makimoto, Go
    Watanabe, Hiromi
    Kudo, Kenichiro
    Matsumoto, Shingo
    Umemura, Shigeki
    Goto, Koichi
    Ichihara, Eiki
    Ninomiya, Takashi
    Kubo, Toshio
    Sato, Akiko
    Hotta, Katsuyuki
    Tabata, Masahiro
    Toyooka, Shinichi
    Maeda, Yoshinobu
    Kiura, Katsuyuki
    CANCER SCIENCE, 2018, 109 (10): : 3149 - 3158
  • [32] Variable ALK Protein and ALK Gene Staining in Inflammatory Myofibroblastic Tumors
    Katzman, Philip J.
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2013, 16 (03) : 232 - 233
  • [33] Uterine Inflammatory Myofibroblastic Tumors Frequently Harbor IGFBP5-ALK and THBS1-ALK Fusions
    Lee, Cheng-Han
    Haimes, Josh
    Kudlow, Brian
    Lee, Jen-Chieh
    McCluggage, W. Glenn
    Ng, Tony
    Stewart, Colin J.
    LABORATORY INVESTIGATION, 2017, 97 : 295A - 296A
  • [34] Clinical benefit of entrectinib for patients with metastatic pancreatic cancer who harbor NTRK and ROS1 fusions.
    Pishvaian, Michael J.
    Rolfo, Christian Diego
    Liu, Stephen V.
    Multani, Pratik S.
    Maneval, Edna Chow
    Garrido-Laguna, Ignacio
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [35] Uterine Inflammatory Myofibroblastic Tumors Frequently Harbor IGFBP5-ALK and THBS1-ALK Fusions
    Lee, Cheng-Han
    Hannes, Josh
    Kudlow, Brian
    Lee, Jen-Chieh
    McCluggage, W. Glenn
    Ng, Tony
    Stewart, Colin J.
    MODERN PATHOLOGY, 2017, 30 : 295A - 296A
  • [36] ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma
    Lee, Jen-Chieh
    Li, Chien-Feng
    Huang, Hsuan-Ying
    Zhu, Mei-Jun
    Marino-Enriquez, Adrian
    Lee, Chung-Ta
    Ou, Wen-Bin
    Hornick, Jason L.
    Fletcher, Jonathan A.
    JOURNAL OF PATHOLOGY, 2017, 241 (03): : 316 - 323
  • [37] Analysis of ROS1 fusions in nonlung solid tumors.
    Yan, Dong
    Xu, Mengxiang
    Wang, Weiran
    Han, Yushuai
    Zhu, Jianhua
    Ma, Tonghui
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [38] MET mediates entrectinib resistance in ROS1 gene fusion positiveNSCLC
    Tyler, Logan
    Anh Le
    Nijmeh, Hala
    Doebele, Robert
    CANCER RESEARCH, 2020, 80 (16)
  • [39] Prolonged response to entrectinib in an adult patient with recurrent glioblastoma harboring a GOPC::ROS1 fusion
    Cerretti, Giulia
    Padovan, Marta
    Guerriero, Angela
    Maccari, Marta
    Bosio, Alberto
    Caccese, Mario
    Cella, Eugenia
    Pintacuda, Giovanna
    Librizzi, Giovanni
    Lombardi, Giuseppe
    NEURO-ONCOLOGY ADVANCES, 2024, 6 (01)
  • [40] Uterine inflammatory myofibroblastic tumor: First report of a ROS1 fusion
    Bennett, Jennifer A.
    Wang, Peng
    Wanjari, Pankhuri
    Diaz, Lidia
    Oliva, Esther
    GENES CHROMOSOMES & CANCER, 2021, 60 (12): : 822 - 826